Renal Physiology and GFR Regulation

🔑 KEY CONCEPT: The kidneys perform three fundamental processes: filtration, reabsorption, and secretion, which collectively maintain fluid-electrolyte balance and eliminate metabolic waste.

Glomerular Filtration Fundamentals

The glomerulus acts as a high-pressure ultrafiltration system, processing approximately 180 L of plasma daily to form 1-2 L of urine. The filtration barrier consists of three layers:

1. Fenestrated endothelium: Prevents cellular elements from crossing
2. Glomerular basement membrane (GBM): Blocks proteins >40 kDa
3. Podocyte foot processes: Creates filtration slits with nephrin proteins

Starling Forces in Glomerular Filtration

Net Filtration Pressure = (PGC - PBS) - (πGC - πBS) Where: PGC = Glomerular capillary hydrostatic pressure (~60 mmHg) PBS = Bowman's space hydrostatic pressure (~15 mmHg) πGC = Glomerular capillary oncotic pressure (~29 mmHg) πBS = Bowman's space oncotic pressure (~0 mmHg)

Net Filtration Pressure = (60 - 15) - (29 - 0) = 16 mmHg

GFR Calculation and Normal Values

GFR = Kf × Net Filtration Pressure

• Normal GFR: 120-130 mL/min/1.73m² (men), 110-120 mL/min/1.73m² (women)
• Filtration fraction (FF) = GFR/RPF ≈ 20%
• Renal plasma flow (RPF) ≈ 600 mL/min

⚡ HIGH-YIELD: GFR decline of >25% suggests significant renal impairment, even with normal serum creatinine due to the kidney's large functional reserve.

Molecular Basis of Selective Filtration

The GBM contains type IV collagen, laminin, and heparan sulfate proteoglycans that create size and charge selectivity. Negatively charged albumin (69 kDa) is largely retained, while smaller neutral molecules freely filter. This selectivity maintains plasma oncotic pressure while allowing waste elimination.

🔬 MECHANISM: Tubular reabsorption recovers 99% of filtered water and essential solutes through both passive and active transport mechanisms distributed along the nephron.

Proximal Tubule Reabsorption (65-70% of filtrate)

Molecular Transport Mechanisms

Apical Membrane (Luminal Side):

• Na⁺-glucose cotransporter (SGLT2 in S1, SGLT1 in S3)
• Na⁺-H⁺ exchanger (NHE3)
• Na⁺-amino acid cotransporters

Basolateral Membrane:

• Na⁺-K⁺-ATPase (primary active transport)
• GLUT2 glucose transporter
• Na⁺-HCO₃⁻ cotransporter (NBC1)

Loop of Henle: Countercurrent Multiplication

Descending Limb (Thin):

• Permeable to H₂O (AQP1)
• Impermeable to NaCl
• Concentrates tubular fluid

Ascending Limb (Thick):

• Impermeable to H₂O
• Active NaCl reabsorption (NKCC2)
• Dilutes tubular fluid
• Creates medullary hypertonicity

⚠️ CLINICAL PEARL: Loop diuretics (furosemide) block NKCC2, disrupting the countercurrent mechanism and reducing concentrating ability.

Distal Convoluted Tubule

The DCT reabsorbs 10-15% of filtered NaCl via the thiazide-sensitive NaCl cotransporter (NCCT). This segment is crucial for fine-tuning electrolyte balance and is the site of action for thiazide diuretics.

Collecting Duct System

Principal cells handle Na⁺ reabsorption and K⁺ secretion via epithelial sodium channels (ENaC), while intercalated cells regulate acid-base balance through H⁺-ATPase and anion exchangers.

🔬 MECHANISM: Active tubular secretion eliminates organic acids, bases, and drugs that aren't effectively filtered, utilizing specific transporters with clinical significance.

Organic Anion Transport (OAT) System

Located primarily in proximal tubule cells, OATs handle:

• Para-aminohippuric acid (PAH) - used to measure RPF
• Penicillin, furosemide, thiazides
• Endogenous compounds: urate, α-ketoglutarate

Transport Mechanism:

Basolateral: α-ketoglutarate/OA⁻ exchanger (OAT1/3) Apical: OA⁻/anion exchanger, ATP-dependent pumps

Organic Cation Transport (OCT) System

Handles positively charged compounds:

• Creatinine (partially)
• Dopamine, histamine
• Drugs: morphine, cimetidine, amiloride

Clinical Applications of Clearance

⚡ HIGH-YIELD: PAH clearance = RPF because PAH is both filtered and secreted, achieving nearly 100% extraction from plasma.

Secretion of Endogenous Compounds

Creatinine Secretion:

• 10-15% of creatinine clearance due to tubular secretion
• Explains why creatinine clearance slightly overestimates GFR
• Medications like cimetidine can block secretion

Potassium Secretion:

• Primary mechanism for K⁺ elimination
• Occurs in collecting duct principal cells
• Regulated by aldosterone, flow rate, and dietary K⁺ intake

Drug Interactions and Clinical Relevance

Competitive inhibition at transporters explains many drug-drug interactions:

• Probenecid blocks penicillin secretion (prolongs antibiotic effect)
• NSAIDs compete with furosemide for OAT transport
• Trimethoprim inhibits creatinine secretion (increases serum creatinine without affecting true GFR)

⚠️ CLINICAL PEARL: Understanding secretion mechanisms is crucial for drug dosing in renal impairment and recognizing potential nephrotoxic interactions.

🔑 KEY CONCEPT: RAAS represents the body's most important long-term blood pressure and volume regulation system, integrating renal, cardiovascular, and endocrine functions.

RAAS Cascade and Molecular Mechanisms

Stimuli → Renin Release → Angiotensin II → Multiple Effects

Stimuli for Renin Release:

1. ↓ Renal perfusion pressure (baroreceptors)
2. ↓ NaCl delivery to macula densa (chemoreceptors)
3. ↑ Sympathetic activity (β₁-adrenergic stimulation)
4. ↑ Prostaglandins (PGE₂, PGI₂)

Enzymatic Steps:

1. Renin (from juxtaglomerular cells): Angiotensinogen → Angiotensin I
2. ACE (pulmonary capillaries, kidney): Angiotensin I → Angiotensin II
3. Alternative pathways: Chymase, cathepsin G (tissue-specific)

Angiotensin II Receptor Subtypes and Effects

Aldosterone Synthesis and Action

Zona Glomerulosa Pathway:

• Angiotensin II → ↑ IP₃/DAG → ↑ Ca²⁺ → ↑ StAR protein → ↑ 11β-hydroxylase
• Hyperkalemia directly stimulates aldosterone synthesis

Mineralocorticoid Effects:

Aldosterone → Mineralocorticoid Receptor → ↑ ENaC expression → ↑ Na⁺-K⁺-ATPase → ↑ ROMK channels Result: ↑ Na⁺ reabsorption, ↑ K⁺ secretion, ↑ H⁺ secretion

⚡ HIGH-YIELD: Aldosterone escape phenomenon: chronic mineralocorticoid excess leads to pressure natriuresis, preventing severe edema despite continued Na⁺ retention.

Negative Feedback Mechanisms

1. Volume expansion → ↑ atrial natriuretic peptide (ANP) → ↓ renin release
2. Angiotensin II → direct negative feedback on renin release
3. High Na⁺ delivery to macula densa → ↓ renin release

Clinical Pharmacology

💊 TREATMENT: RAAS inhibitors form the backbone of cardiovascular medicine:

• ACE inhibitors: Block Ang I → Ang II conversion
• ARBs: Block AT₁ receptors selectively
• Aldosterone antagonists: Spironolactone (competitive), eplerenone (selective)
• Direct renin inhibitors: Aliskiren (limited clinical use)

⚠️ CLINICAL PEARL: ACE inhibitors cause dry cough (10-15% patients) due to bradykinin accumulation, while ARBs do not affect bradykinin metabolism.

🔬 MECHANISM: ADH (vasopressin) represents the primary mechanism for fine-tuning water balance, operating through osmotic and volume-pressure sensing pathways.

ADH Synthesis and Release

Hypothalamic-Pituitary Axis:

• Synthesized in supraoptic and paraventricular nuclei
• Transported via neurophysin carriers to posterior pituitary
• Stored in Herring bodies until release

Stimuli for ADH Release:

Osmotic Stimuli (Primary):

• Osmoreceptors in anterior hypothalamus
• Threshold: 280-285 mOsm/kg H₂O
• Sensitivity: 1-2% change in osmolality

Non-osmotic Stimuli:

• Volume depletion >10-15% (arterial baroreceptors)
• Pain, nausea, stress
• Medications: morphine, nicotine, cyclophosphamide

Molecular Mechanism of ADH Action

V₂ Receptor Pathway (Collecting Duct):

ADH → V₂ Receptor → Gs protein → ↑ cAMP → ↑ PKA ↓ Aquaporin-2 (AQP2) phosphorylation → Vesicle fusion with apical membrane → ↑ Water permeability (>50-fold increase)

Chronic ADH Effects:

• ↑ AQP2 gene transcription
• ↑ Urea transporter (UT-A1) expression
• Enhanced medullary hypertonicity

Countercurrent Concentration Mechanism

Urine Concentration Process:

1. Cortical collecting duct: Initial water reabsorption
2. Medullary collecting duct: Final concentration up to 1200 mOsm/kg
3. Urea recycling: UT-A1 transporters maintain medullary gradient

⚡ HIGH-YIELD: Maximum urine concentration depends on medullary hypertonicity, not just ADH levels. Loop diuretics impair concentrating ability by disrupting the gradient.

Clinical Disorders of ADH

Central Diabetes Insipidus:

• ADH deficiency (hypothalamic/pituitary lesions)
• Polyuria (>3L/day), polydipsia, hypernatremia
• Treatment: Desmopressin (DDAVP)

Nephrogenic Diabetes Insipidus:

• Renal resistance to ADH
• Causes: Lithium, hypercalcemia, genetic V₂R mutations
• Treatment: Thiazide diuretics, amiloride

SIADH (Syndrome of Inappropriate ADH):

• Excessive ADH release or action
• Euvolemic hyponatremia, concentrated urine
• Causes: CNS disorders, lung diseases, medications

⚠️ CLINICAL PEARL: Water restriction test distinguishes central DI (responds to desmopressin) from nephrogenic DI (no response to desmopressin).

🔑 KEY CONCEPT: GFR autoregulation maintains stable filtration rates despite blood pressure fluctuations (80-180 mmHg), ensuring consistent kidney function across physiological conditions.

Autoregulation Mechanisms

Myogenic Response:

↑ Blood Pressure → ↑ Vascular Stretch → Ca²⁺ Channel Activation → Smooth Muscle Contraction → Afferent Arteriole Constriction → Maintained Glomerular Pressure

• Intrinsic vascular smooth muscle property
• Response time: seconds
• Effective range: 80-180 mmHg

Tubuloglomerular Feedback (TGF):

TGF Mechanism:

↑ GFR → ↑ NaCl Delivery to Macula Densa → ↑ Adenosine Production → A1 Receptor Activation → Afferent Arteriole Constriction → ↓ GFR (Negative Feedback)

⚡ HIGH-YIELD: TGF has a longer response time (30-60 seconds) but provides more precise regulation than myogenic response.

Neural and Hormonal Control

Sympathetic Nervous System:

• α₁-adrenergic receptors: Afferent/efferent arteriole constriction
• β₁-adrenergic receptors: ↑ Renin release from JG cells
• High sympathetic activity (stress, hemorrhage): ↓ GFR, ↑ RAAS activation

Endothelial Factors:

Vasodilators:

• Nitric Oxide (NO): ↑ cGMP → vasodilation
• Prostacyclin (PGI₂): ↑ cAMP → vasodilation
• Endothelin (ET-1): Via ETB receptors → NO release

Vasoconstrictors:

• Endothelin-1: Via ETA receptors → vasoconstriction
• Thromboxane A₂: Platelet-derived → vasoconstriction
• Angiotensin II: AT₁ receptors → vasoconstriction

Pathophysiological Alterations

Hypertensive Nephrosclerosis:

• Impaired autoregulation → pressure transmission to glomerulus
• Progressive mesangial sclerosis and tubular atrophy
• "Pressure natriuresis" shifted to higher pressure range

Diabetic Nephropathy:

• Early hyperfiltration (↑ GFR due to afferent vasodilation)
• Progressive loss of autoregulation
• Glomerular hypertension → sclerosis

Acute Kidney Injury:

• Autoregulation failure → GFR dependent on perfusion pressure
• Tubular obstruction → ↑ back-pressure
• Inflammatory mediators → altered vascular reactivity

Clinical Implications

💊 TREATMENT: Understanding GFR regulation guides therapeutic interventions:

• ACE inhibitors/ARBs: Preferentially dilate efferent arterioles → ↓ intraglomerular pressure
• Calcium channel blockers: Interfere with myogenic response
• NSAIDs: Block prostaglandin synthesis → impaired autoregulation

⚠️ CLINICAL PEARL: Elderly patients and those with renovascular disease have impaired autoregulation, making them vulnerable to hypotension-induced AKI during anesthesia or aggressive antihypertensive therapy.

⚡ HIGH-YIELD: Understanding normal renal physiology is essential for recognizing pathological states and guiding therapeutic interventions in clinical practice.

Chronic Kidney Disease (CKD) Pathophysiology

Progressive GFR Decline:

CKD Stages (based on GFR mL/min/1.73m²): Stage 1: ≥90 (normal/high with kidney damage) Stage 2: 60-89 (mildly decreased) Stage 3a: 45-59 (moderately decreased) Stage 3b: 30-44 (moderately decreased) Stage 4: 15-29 (severely decreased) Stage 5: <15 (kidney failure)

Compensatory Mechanisms:

• Hyperfiltration in remaining nephrons
• Enhanced tubular secretion (creatinine, organic anions)
• Increased synthesis of calcitriol, EPO initially

Uremic Toxin Accumulation:

• Small molecules: Urea, creatinine, guanidines
• Middle molecules: β₂-microglobulin, parathyroid hormone
• Protein-bound toxins: Indoxyl sulfate, p-cresyl sulfate

Electrolyte and Acid-Base Disorders

Drug Dosing in Renal Impairment

Principles of Dose Adjustment:

1. Identify renally eliminated drugs (>30% unchanged renal excretion)
2. Calculate dose adjustment based on creatinine clearance
3. Monitor for toxicity of active metabolites
4. Consider dialyzability for drug removal

High-Risk Medications:

Dose Reduction Required:

• Digoxin, lithium, aminoglycosides
• Metformin (contraindicated if GFR <30)
• ACE inhibitors/ARBs (monitor for hyperkalemia)
• Gadolinium contrast (nephrogenic systemic fibrosis risk)

Diagnostic Applications

GFR Estimation Methods:

• Cockcroft-Gault: (140-age) × weight / (72 × SCr) × 0.85 (if female)
• MDRD: More accurate for GFR <60 mL/min/1.73m²
• CKD-EPI: Most accurate across all GFR ranges
• Cystatin C: Less affected by muscle mass

⚠️ CLINICAL PEARL: Serum creatinine may remain normal until GFR falls below 50% due to compensatory hypersecretion and reduced muscle mass in elderly patients.

Therapeutic Interventions

💊 TREATMENT: Evidence-based strategies to slow CKD progression:

Primary Prevention:

• Blood pressure control (<130/80 mmHg)
• Diabetes management (HbA1c <7%)
• Proteinuria reduction with RAAS inhibitors
• Smoking cessation, weight management

Secondary Prevention:

• Phosphate binders for hyperphosphatemia
• Calcitriol analogues for secondary hyperparathyroidism
• Erythropoiesis-stimulating agents for anemia
• Sodium bicarbonate for metabolic acidosis

Renal Replacement Therapy Considerations:

• Hemodialysis: Requires vascular access, 3×/week
• Peritoneal dialysis: Uses peritoneum as dialyzing membrane
• Kidney transplantation: Best long-term option for eligible patients

Mnemonic for Renal Functions: "BEAVERS"

• Blood pressure regulation (RAAS)
• Erythropoietin production
• Acid-base balance
• Vitamin D activation
• Electrolyte homeostasis
• Removal of waste products
• Salt and water balance